{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:29:44Z","timestamp":1787977784777,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["03V0538"],"award-info":[{"award-number":["03V0538"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00394-019-01974-x","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T13:10:09Z","timestamp":1556889009000},"page":"1135-1147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Plasma concentrations and ACE-inhibitory effects of tryptophan-containing peptides from whey protein hydrolysate in healthy volunteers"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2524-3124","authenticated-orcid":false,"given":"Melanie","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thinh Trung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats Leif","family":"Moskopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Henle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Deussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"key":"1974_CR1","first-page":"176","volume-title":"Global status report on noncommunicable diseases 2014","author":"World Health Organization (WHO)","year":"2014","unstructured":"World Health Organization (WHO) (2014) Global status report on noncommunicable diseases 2014. WHO, Geneve, p 176"},{"key":"1974_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s40292-015-0120-5","volume":"22","author":"C Borghi","year":"2015","unstructured":"Borghi C, Rossi F (2015) Role of the renin\u2013angiotensin\u2013aldosterone system and its pharmacological inhibitors in cardiovascular diseases: complex and critical issues. High Blood Press Cardiovasc Prev 22:429\u2013444","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"1974_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1210\/er.2003-0001","volume":"24","author":"RM Carey","year":"2003","unstructured":"Carey RM, Siragy HM (2003) Newly recognized components of the renin\u2013angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 24:261\u2013271","journal-title":"Endocr Rev"},{"key":"1974_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1161\/HYPERTENSIONAHA.110.167775","volume":"57","author":"C Fanelli","year":"2011","unstructured":"Fanelli C, Zatz R (2011) Linking oxidative stress, the renin\u2013angiotensin system and hypertension. Hypertension 57:373\u2013374","journal-title":"Hypertension"},{"key":"1974_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145\u2013153","journal-title":"N Engl J Med"},{"key":"1974_CR6","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S0140-6736(03)14974-4","volume":"362","author":"KM Fox","year":"2003","unstructured":"Fox KM (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362:782\u2013788","journal-title":"Lancet"},{"key":"1974_CR7","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa032292","volume":"349","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, McMurray JJV, Velazquez EJ, Rouleau JL, K\u00f8ber L, Aldo P, Maggioni MD, Solomon S, Swedberg K, Van de Werf F, White H et al (2003) Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349:1893\u20131906","journal-title":"N Engl J Med"},{"key":"1974_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2147\/VHRM.S29138","volume":"8","author":"S Collier","year":"2012","unstructured":"Collier S, Landram M (2012) Treatment of prehypertension: lifestyle and\/or medication. Vasc Health Risk Manag 8:613\u2013619","journal-title":"Vasc Health Risk Manag"},{"key":"1974_CR9","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560\u20132572","journal-title":"JAMA"},{"key":"1974_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijcard.2017.05.003","volume":"240","author":"C Tao","year":"2017","unstructured":"Tao C, Dahai Y, Cornelius V, Rui Q, Yamei C, Zhixin J, Zhanzheng Z (2017) Potential health impact and cost-effectiveness of drug therapy for prehypertension. Int J Cardiol 240:403\u2013408","journal-title":"Int J Cardiol"},{"key":"1974_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ijcard.2016.11.044","volume":"227","author":"MH Jung","year":"2017","unstructured":"Jung MH, Ihmb SH, Lee DH, Chung WB, Jung HO, Youn HJ (2017) Prehypertension is associated with early complications of atherosclerosis but not with exercise capacity. Int J Cardiol 227:387\u2013392","journal-title":"Int J Cardiol"},{"key":"1974_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.idairyj.2005.10.012","volume":"16","author":"H Korhonen","year":"2006","unstructured":"Korhonen H, Pihlanto A (2006) Bioactive peptides: production and functionality. Int Dairy 16:945\u2013996","journal-title":"Int Dairy"},{"key":"1974_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00217-013-2014-x","volume":"237","author":"D Lunow","year":"2013","unstructured":"Lunow D, Kaiser S, Br\u00fcckner S, Gotsch A, Henle T (2013) Selective release of ACE-inhibiting tryptophan-containing dipeptides from food proteins by enzymatic hydrolysis. Eur Food Res Technol 237:27\u201337","journal-title":"Eur Food Res Technol"},{"key":"1974_CR14","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.foodchem.2014.06.059","volume":"166","author":"D Lunow","year":"2015","unstructured":"Lunow D, Kaiser S, R\u00fcckriemen J, Pohl C, Henle T (2015) Tryptophan-containing dipeptides are C-domain selective inhibitors of angiotensin converting enzyme. Food Chem 166:596\u2013602","journal-title":"Food Chem"},{"key":"1974_CR15","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1021\/jf800865b","volume":"56","author":"M Martin","year":"2008","unstructured":"Martin M, Wellner A, Ossowski I, Henle T (2008) Identification and quantification of inhibitors for Angiotensin-converting enzyme in hypoallergenic infant milk formulas. J Agric Food Chem 56:6333\u20136338","journal-title":"J Agric Food Chem"},{"key":"1974_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev.physiol.66.032102.144149","volume":"66","author":"H Daniel","year":"2004","unstructured":"Daniel H (2004) Molecular and integrative physiology of intestinal peptide transport. Annu Rev Physiol 66:361\u2013384","journal-title":"Annu Rev Physiol"},{"key":"1974_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.idairyj.2015.09.004","volume":"52","author":"S Kaiser","year":"2016","unstructured":"Kaiser S, Martin M, Lunow D, Rudolph S, Mertten S, Moeckel U, Deussen A, Henle T (2016) Tryptophan-containing dipeptides are bioavailable and inhibit plasma human angiotensin-converting enzyme in vivo. Int Dairy J 52:107\u2013114","journal-title":"Int Dairy J"},{"key":"1974_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1046\/j.1440-1681.2002.03628.x","volume":"29","author":"T Matsui","year":"2002","unstructured":"Matsui T, Tamaya K, Seki E, Osajima K, Matsumoto K, Kawasaki T (2002) Val-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system. Clin Exp Pharmacol Physiol 29:204\u2013208","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1974_CR19","first-page":"1845","volume":"65","author":"DL Swagerty Jr","year":"2002","unstructured":"Swagerty DL Jr, Walling AD, Klein RM (2002) Lactose intolerance. Am Fam Physician 65:1845\u20131850","journal-title":"Am Fam Physician"},{"key":"1974_CR20","first-page":"1","volume-title":"Technical report series 935: protein and amino acid requirements in human nutrition","author":"FAO\/WHO\/UNU","year":"2017","unstructured":"FAO\/WHO\/UNU (2017) Technical report series 935: protein and amino acid requirements in human nutrition. WHO Press, Geneva, pp 1\u2013265"},{"key":"1974_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/bjaceaccp\/mkh020","volume":"4","author":"P Foex","year":"2004","unstructured":"Foex P, Sear J (2004) Hypertension: pathophysiology and treatment. Contin Educ Anaesth Crit Care Pain 4:71\u201375","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"1974_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0011-5029(96)90019-X","volume":"42","author":"BE Akpunonu","year":"1996","unstructured":"Akpunonu BE, Mulrow PJ, Hoffman EA (1996) Secondary hypertension: evaluation and treatment. Dis Mon 42:609\u2013722","journal-title":"Dis Mon"},{"key":"1974_CR23","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1051\/rnd:19800713","volume":"20","author":"T Corring","year":"1980","unstructured":"Corring T (1980) The adaptation of digestive enzymes to the diet: its physiological significance. Reprod Nutr Dev 20:1217\u20131235","journal-title":"Reprod Nutr Dev"},{"key":"1974_CR24","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1021\/acs.jafc.7b05655","volume":"66","author":"X Ma","year":"2018","unstructured":"Ma X, Tian Z, Deng D, Cui Y, Qiu Y (2018) Effect of dietary protein level on the expression of proteins in the gastrointestinal tract of young pigs. J Agric Food Chem 66:4364\u20134372","journal-title":"J Agric Food Chem"},{"key":"1974_CR25","first-page":"2","volume":"4","author":"S Khedr","year":"2015","unstructured":"Khedr S, Martin M, Deussen A (2015) Inhibitory efficacy and biological variability of tryptophan containing dipeptides on human plasma angiotensin converting enzyme activity. J Hypertens Open Access 4:2\u20136","journal-title":"J Hypertens Open Access"},{"key":"1974_CR26","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1152\/ajpgi.2001.281.3.G697","volume":"281","author":"DA Groneberg","year":"2001","unstructured":"Groneberg DA, D\u00f6ring F, Eynott PR, Fischer A, Daniel H (2001) Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. Am J Physiol Gastrointest Liver Physiol 281:697\u2013704","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1974_CR27","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1124\/dmd.110.034025","volume":"38","author":"D Jappar","year":"2010","unstructured":"Jappar D, Wu SP, Hu Y, Smith DE (2010) Significance and regional dependency of peptide transporter (PEPT) 1 in the intestinal permeability of glycylsarcosine: in situ single-pass perfusion studies in wild-type and Pept1 knockout mice. Drug Metab Dispos 38:1740\u20131746","journal-title":"Drug Metab Dispos"},{"key":"1974_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.mam.2012.11.003","volume":"34","author":"DE Smith","year":"2013","unstructured":"Smith DE, Cl\u00e9men\u00e7on B, Hediger MA (2013) Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol Asp Med 34:323\u2013336","journal-title":"Mol Asp Med"},{"key":"1974_CR29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1469-7793.1998.697bs.x","volume":"507","author":"D Walker","year":"1998","unstructured":"Walker D, Thwaites DT, Simmons NL, Gilbert HJ, Hirst BH (1998) Substrate upregulation of the human small intestinal peptide transporter, hPepT1. J Physiol 507:697\u2013706","journal-title":"J Physiol"},{"key":"1974_CR30","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1152\/ajpgi.00477.2011","volume":"302","author":"SA Ingersoll","year":"2012","unstructured":"Ingersoll SA, Ayyadurai S, Charania MA, Laroui H, Yan Y, Merlin D (2012) The role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 302:484\u2013492","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1974_CR31","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.2147\/DDDT.S151725","volume":"11","author":"C-Y Wang","year":"2017","unstructured":"Wang C-Y, Liu S, Xie X-N, Tan Z-R (2017) Regulation profile of the intestinal peptide transporter 1 (PepT1). Drug Des Devel Ther 11:3511\u20133517","journal-title":"Drug Des Devel Ther"},{"key":"1974_CR32","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.peptides.2005.08.012","volume":"27","author":"H Lu","year":"2016","unstructured":"Lu H, Klaassen C (2016) Tissue distribution and thyroid hormone regulation of Pept1 and Pept2 mRNA in rodents. Peptides 27:850\u2013857","journal-title":"Peptides"},{"key":"1974_CR33","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00394-016-1374-y","volume":"57","author":"S Khedr","year":"2018","unstructured":"Khedr S, Deussen A, Kopaliani I, Zatschler B, Martin M (2018) Effects of tryptophan-containing peptides on angiotensin converting enzyme activity and vessel tone ex vivo and in vivo. Eur J Nutr 57:907\u2013915","journal-title":"Eur J Nutr"},{"key":"1974_CR34","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1021\/jf5035256","volume":"62","author":"L Sanchez-Rivera","year":"2014","unstructured":"Sanchez-Rivera L, Ares I, Miralles B, Gomez-Ruiz J-A, Recio I, Martinez-Larranaga MR, Anadon A, Martinez MA (2014) Bioavailability and kinetics of the antihypertensive casein-derived peptide HLPLP in rats. J Agric Food Chem 62:1869\u20131875","journal-title":"J Agric Food Chem"},{"key":"1974_CR35","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.peptides.2008.08.011","volume":"29","author":"P van der Pijl","year":"2008","unstructured":"van der Pijl P, Kies AK, Ten Have GAM, Duchateau GSMJE, Deutz EP (2008) Pharmacokinetics of proline-rich tripeptides in the pig. Peptides 29:2196\u20132202","journal-title":"Peptides"},{"key":"1974_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/psc.568","volume":"10","author":"T Matsui","year":"2004","unstructured":"Matsui T, Imamura M, Oka H, Osajima K, Kimoto K-I, Kawasaki T, Masumoto T (2004) Tissue distribution of antihypertensive dipeptide, Val-Tyr, after its single oral administration to spontaneously hypertensive rats. J Peptide Sci 10:535\u2013545","journal-title":"J Peptide Sci"},{"key":"1974_CR37","doi-asserted-by":"publisher","first-page":"11471","DOI":"10.1021\/jf102538g","volume":"58","author":"H Li","year":"2010","unstructured":"Li H, Aluko RE (2010) Identification and inhibitory properties of multifunctional peptides from pea protein hydrolysate. J Agric Food Chem 58:11471\u201311476","journal-title":"J Agric Food Chem"},{"key":"1974_CR38","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/HJH.0b013e32832b4759","volume":"27","author":"G Wuerzner","year":"2009","unstructured":"Wuerzner G, Peyrard S, Blanchard A, Lalanne F, Azizi M (2009) The lactotripeptides isoleucine-proline-proline and valine-proline-proline do not inhibit the N-terminal or C-terminal angiotensin converting enzyme active sites in humans. J Hypertens 27:1404\u20131409","journal-title":"J Hypertens"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-019-01974-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00394-019-01974-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-019-01974-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T23:13:23Z","timestamp":1588374803000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00394-019-01974-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1974"],"URL":"https:\/\/doi.org\/10.1007\/s00394-019-01974-x","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"assertion":[{"value":"18 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare that all human studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}